Literature DB >> 30854467

The cost of not addressing the communication barriers faced by hospitalized patients.

Richard R Hurtig1, Rebecca M Alper2, Benjamin Berkowitz3.   

Abstract

Preventable adverse events (AEs) lead to poorer patient outcomes, added patient suffering and dissatisfaction, longer hospital stays, and billions in additional annual healthcare spending. Patients facing barriers to communication are three times more likely to experience a preventable adverse event than patients who faced no communication barriers. National data on hospital admissions, incidence and cost of preventable AEs, and the odds ratio regarding the risk of preventable AEs in people facing communication barriers were used to estimate potential benefits of improving patient communication. Reducing communication barriers could lead to an estimated reduction of 671,440 preventable AE cases and a cost savings of $6.8 billion annually. Facilitating patient-provider communication is an ethical and financial imperative. A multi-pronged approach, including increased awareness of and support for speech-language pathology services, is essential to creating a communication-friendly hospital culture, reducing patient suffering, and decreasing the financial cost of preventable AEs. Speech-language pathologists and allied healthcare professionals play a critical role in facilitating patient-provider communication and improving patient outcomes.

Entities:  

Keywords:  Adverse Medical Events; Augmentative and Alternative Communication; Costs of Adverse Events; Patient safety and prevention of medical error; Patient-Provider Communication

Year:  2018        PMID: 30854467      PMCID: PMC6402813          DOI: 10.1044/persp3.SIG12.99

Source DB:  PubMed          Journal:  Perspect ASHA Spec Interest Groups


  30 in total

Review 1.  The increasing medical malpractice risk related to pressure ulcers in the United States.

Authors:  R G Bennett; J O'Sullivan; E M DeVito; R Remsburg
Journal:  J Am Geriatr Soc       Date:  2000-01       Impact factor: 5.562

2.  Exploring the causes of adverse events in NHS hospital practice.

Authors:  G Neale; M Woloshynowych; C Vincent
Journal:  J R Soc Med       Date:  2001-07       Impact factor: 5.344

3.  Adverse events in New Zealand public hospitals I: occurrence and impact.

Authors:  Peter Davis; Roy Lay-Yee; Robin Briant; Wasan Ali; Alastair Scott; Stephan Schug
Journal:  N Z Med J       Date:  2002-12-13

4.  Effect of communication disability on satisfaction with health care: a survey of medicare beneficiaries.

Authors:  Jeanne M Hoffman; Kathryn M Yorkston; Anne Shumway-Cook; Marcia A Ciol; Brian J Dudgeon; Leighton Chan
Journal:  Am J Speech Lang Pathol       Date:  2005-08       Impact factor: 2.408

Review 5.  Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Authors:  A Blenkinsopp; P Wilkie; M Wang; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

6.  Language proficiency and adverse events in US hospitals: a pilot study.

Authors:  Chandrika Divi; Richard G Koss; Stephen P Schmaltz; Jerod M Loeb
Journal:  Int J Qual Health Care       Date:  2007-02-02       Impact factor: 2.038

7.  Are language barriers associated with serious medical events in hospitalized pediatric patients?

Authors:  Adam L Cohen; Frederick Rivara; Edgar K Marcuse; Heather McPhillips; Robert Davis
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

8.  Daily cost of an intensive care unit day: the contribution of mechanical ventilation.

Authors:  Joseph F Dasta; Trent P McLaughlin; Samir H Mody; Catherine Tak Piech
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

9.  Communicating with nurses: the experiences of 10 adults with cerebral palsy and complex communication needs.

Authors:  Susan Balandin; Bronwyn Hemsley; Jeff Sigafoos; Vanessa Green
Journal:  Appl Nurs Res       Date:  2007-05       Impact factor: 2.257

10.  Patients' reports of health care practitioner interventions that are related to communication during mechanical ventilation.

Authors:  Lance Patak; Anna Gawlinski; Ng Irene Fung; Lynn Doering; Jill Berg
Journal:  Heart Lung       Date:  2004 Sep-Oct       Impact factor: 2.210

View more
  7 in total

1.  The Experience of COVID-19 Visitor Restrictions among Families of People Living in Long-Term Residential Care Facilities during the First Wave of the Pandemic in Ireland.

Authors:  Nicola Cornally; Caroline Kilty; Catherine Buckley; Rónán O'Caoimh; Mark R O'Donovan; Margaret P Monahan; Caroline Dalton O'Connor; Serena Fitzgerald; Irene Hartigan
Journal:  Int J Environ Res Public Health       Date:  2022-05-27       Impact factor: 4.614

2.  Developing a Culture of Successful Communication in Acute Care Settings: Part II. Solving Institutional Issues.

Authors:  Sarah Marshall; Richard R Hurtig
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-31

3.  Developing a Culture of Successful Communication in Acute Care Settings: Part I. Solving Patient-Specific Issues.

Authors:  Sarah Marshall; Richard R Hurtig
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-31

4.  Personalization of Patient-Provider Communication Across the Lifespan.

Authors:  Jessica Gormley; Susan Koch Fager
Journal:  Top Lang Disord       Date:  2021

5.  Clinical communication in inflammatory bowel disease: a systematic literature review protocol.

Authors:  Neda Karimi; Alison Rotha Moore; Annabelle Lukin; Ria Kanazaki; Astrid-Jane Williams; Susan Connor
Journal:  BMJ Open       Date:  2020-11-04       Impact factor: 2.692

6.  Above cuff vocalisation (ACV): A scoping review.

Authors:  Antonija Petosic; Marit F Viravong; Anna M Martin; Cecilie B Nilsen; Kjell Olafsen; Helene Berntzen
Journal:  Acta Anaesthesiol Scand       Date:  2020-11-01       Impact factor: 2.105

7.  Improving Patient Safety and Patient-Provider Communication.

Authors:  Richard R Hurtig; Rebecca M Alper; Karen N T Bryant; Krista R Davidson; Chelsea Bilskemper
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.